Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-21

Clinical Trial Update: Booster Dose of HCG for Unruptured Follicle in Non IVF/ICSI Cycles [Phase 4]

View source ↗

Summary

Phase 4 trial update on booster dose of hCG for luteinised unruptured follicle syndrome in non-IVF/ICSI cycles has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • hCG (human chorionic gonadotropin)

Snippet

Sponsor: Tanta University | Conditions: LUF - Luteinised Unruptured Follicle Syndrome | Phase 4 | Status: COMPLETED